BLLN

BillionToOne, Inc. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-03-11

Figures on this page computed 2026-11-08 12:56 UTC

Last close

113.94USD

Market data, 2026-11-06

Except where said otherwise: 10-K for 2025, filed 2026-03-11

633.0xP/E
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0002070849-26-000017
Reported in
USD
- computed
- 10-K for 2025, filed 2026-03-11
The filing itself
16.6%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0002070849-26-000017
Reported in
USD
- 10-K for 2025, filed 2026-03-11
- 10-K for 2025, filed 2026-03-11
- 10-K for 2025, filed 2026-03-11
- 10-Q for 2025, filed 2026-11-04
- 10-K for 2025, filed 2026-03-11
- 10-Q for 2025, filed 2026-11-04
The filing itself
2.4%Net margin
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0002070849-26-000017
Reported in
USD
- 10-K for 2025, filed 2026-03-11
- 10-K for 2025, filed 2026-03-11
The filing itself
5.2%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0002070849-26-000017
Reported in
USD
- 10-K for 2025, filed 2026-03-11
- 10-K for 2025, filed 2026-03-11
The filing itself
0.23Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0002070849-26-000017
Reported in
USD
- 10-K for 2025, filed 2026-03-11
- 10-Q for 2025, filed 2026-11-04
The filing itself
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Price is the furthest below its sector's middle: 0.04 against 0.36 on the market's range.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Then and now

lens 3 of 9

Five filed facts, 2023 against 2025.
Fact	2023	2025	Change
Sales	71,729,000	305,112,000	+325%
Profit	-82,683,000	7,454,000	+109%
Free cash flow	-59,846,000	15,714,000	+126%
Debt	n/a	108,895,000	n/a
Shares in issue	9,782,770	21,230,752	+117%

The same five facts for 2023 and 2025, each read from the year's own filing.

Every figure in this lens

Except where said otherwise: 10-K for 2023, filed 2026-03-11

Sales, 202371,729,000
Source
filed
Statement
income
Fiscal year
2023
Accession
0002070849-26-000017
Reported in
USD
The filing itself
Sales, 2025305,112,00010-K for 2025, filed 2026-03-11
Source
filed
Statement
income
Fiscal year
2025
Accession
0002070849-26-000017
Reported in
USD
The filing itself
Profit, 2023-82,683,000
Source
filed
Statement
income
Fiscal year
2023
Accession
0002070849-26-000017
Reported in
USD
The filing itself
Profit, 20257,454,00010-K for 2025, filed 2026-03-11
Source
filed
Statement
income
Fiscal year
2025
Accession
0002070849-26-000017
Reported in
USD
The filing itself
Free cash flow, 2023-59,846,000
Source
filed
Statement
income
Fiscal year
2023
Accession
0002070849-26-000017
Reported in
USD
The filing itself
Free cash flow, 202515,714,00010-K for 2025, filed 2026-03-11
Source
filed
Statement
income
Fiscal year
2025
Accession
0002070849-26-000017
Reported in
USD
The filing itself
Debt, 2023n/a
Not held.
Source
filed
Statement
income
Fiscal year
2023
Accession
0002070849-26-000017
Reported in
USD
The filing itself
Debt, 2025108,895,00010-K for 2025, filed 2026-03-11
Source
filed
Statement
income
Fiscal year
2025
Accession
0002070849-26-000017
Reported in
USD
The filing itself
Shares in issue, 20239,782,770
Source
filed
Statement
income
Fiscal year
2023
Accession
0002070849-26-000017
Reported in
USD
The filing itself
Shares in issue, 202521,230,75210-K for 2025, filed 2026-03-11
Source
filed
Statement
income
Fiscal year
2025
Accession
0002070849-26-000017
Reported in
USD
The filing itself